Keyphrases
Mesenchymal Stem Cells
88%
T Helper 17 (Th17)
28%
Systemic Lupus Erythematosus
28%
T Cells
23%
Human Mesenchymal Stem Cells (hMSCs)
17%
Endometrial Stem Cells
15%
Experimental Autoimmune Encephalomyelitis
15%
Interleukin-17 (IL-17)
14%
Rat Model
14%
Rheumatic Heart Disease
14%
Chronic Kidney Disease
14%
Rheumatic Fever
14%
Cell Therapy
14%
Mesenchymal Stromal Cells
13%
Th1 Cells
12%
Autoimmune Disease
11%
Heart Failure Patients
11%
Stem Cell Therapy
11%
Systemic Lupus Erythematosus Patient
10%
Valvular
10%
Stem Cells
9%
Mesenchymal Stem Cell Therapy
9%
Toll-like
9%
Human Umbilical Cord Mesenchymal Stromal Cells
9%
Mitochondrial Transfer
9%
Tissue Damage
8%
Disease Activity
8%
Phase II Trial
8%
Cell-based
7%
Group A Streptococcus
7%
Intravenous Infusion
7%
Immunosuppressive Properties
7%
Stem Cell-derived
6%
Inflammatory Response
6%
Transplantation
6%
Immunosuppression
6%
Differentiation Potential
6%
Clinical Diagnosis
6%
Bromocriptine
6%
Cellular Immune Response
6%
Secreted Factors
6%
Graft-versus-host Disease (GvHD)
6%
Rheumatoid Arthritis
6%
CD8+ T Cells
6%
Patients with Heart Failure
6%
Myocardial Infarction
6%
Etiology
6%
Randomized Clinical Trial
6%
Organ Damage
6%
Cardiovascular Disease
5%
Therapeutic Effect
5%
Adaptive Immune Response
5%
Interleukin-2
5%
MicroRNA
5%
Peripheral Blood Mononuclear Cells
5%
Latin American
5%
Adipose-derived Stromal Cells
5%
Bone Marrow Mononuclear Cells
5%
Treg Lymphocytes
5%
Regenerative Properties
5%
Treg Differentiation
5%
Innate Immune Response
5%
Stem Cell Delivery
5%
Superantigen
5%
CD4+CD25+Foxp3+
5%
Regulatory T Cells
5%
Immunomodulatory Effect
5%
Immunosuppressive Potential
5%
Immunomodulatory Properties
5%
Immunology and Microbiology
Mesenchymal Stem Cell
100%
Systemic Lupus Erythematosus
28%
Immunosuppressive Drug
25%
T Cell
24%
Th17 Cell
19%
Experimental Autoimmune Encephalomyelitis
16%
Regulatory T Cell
15%
Rat Model
14%
Stem Cell
14%
Autoimmune Disease
13%
Th1 Cell
12%
Bone Marrow Derived Mesenchymal Stem Cell
11%
Immunity
10%
Cytokine
10%
CD4
10%
T-Helper Cell
10%
Arthritis
9%
Rheumatic Heart Disease
9%
Interleukin 6
7%
Cytotoxic T-Cell
7%
Cell Population
7%
Inflammation Response
7%
Umbilical Cord
6%
Lupus Erythematosus
6%
T Cell Activation
6%
Graft-Versus-Host Disease
6%
CD25
5%
Immune System
5%
Toll-Like Receptor
5%
Stem Cell Transplantation
5%
Inflammatory Arthritis
5%
Streptococcus Group A
5%
TLR3
5%
Innate Immune System
5%
Adaptive Immune System
5%
Autoimmunity
5%
Superantigen
5%
Medicine and Dentistry
Mesenchymal Stem Cell
44%
Systemic Lupus Erythematosus
24%
Stem Cell
17%
T Cell
15%
Rheumatic Heart Disease
14%
Disease
13%
Rheumatic Fever
13%
Infection
11%
Cell Therapy
11%
Umbilical Cord
11%
Bone Marrow Derived Mesenchymal Stem Cell
10%
Receptor
9%
Congestive Heart Failure
7%
Streptococcus Group A
7%
Autoimmune Disease
7%
Immunosuppressive Drug
6%
Quality of Life
6%
Cardiovascular Disease
6%
Randomized Clinical Trial
6%
Stem Cell Therapy
6%
Programmed Cell Death
6%
Experimental Autoimmune Encephalomyelitis
5%
microRNA
5%
Stromal Cell
5%
Cytotoxic T-Cell
5%
Intravenous Drug Administration
5%
Immunity
5%
Carditis
5%
Th17 Cell
5%
In Vitro
5%
Superantigen
5%
Adipose Tissue
5%